Dacarbazine powder 100mg
Dacarbazine powder 200mg
Dacarbazine powder 500mg
Browse Alphabetically:
A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #
Information about ExpressMedsCanada.com
List of countries where we can ship Dacarbazine:
Latest news releases on Dacarbazine:
The results from an abstract, or brief summary, of the study showed that Zelboraf led to a median overall survival of 13.2 months compared with 9.6 months for those who received dacarbazine chemotherapy. That translates into a 38 percent ...
The study is randomized 2:2:1 twice the number of patients get Allovectin-7, so there will be about 260 patients getting Allovectin-7 and about 130 getting Dacarbazine. The study is not blinded to the doctors and the patients. It’s blinded to us ...
We will find out in a couple of weeks. In Hodgkin lymphoma studies, there is yet another comparison of ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) vs escalated BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide ...
There currently are two trials in the works with dabrafenib in melanoma: a phase II study in patients with asymptomatic brain metastases and a phase III randomized, controlled trial of dabrafenib compared with dacarbazine (Dtic-Dome).
Cytotoxics such as dacarbazine and other off-label drugs including temozolomide, cisplatin and paclitaxel. The growth of the market is primarily due to the new product approvals and increase in the incidence rates during the forecast period. Due to these ...
In August 2010 she was enrolled into the BRIM3 trial and after the randomization process she received dacarbazine. After two cycles, there was evidence of disease progression in her peritoneum and lung. For this reason, she was enrolled into another ...
dacarbazine, and members of the platinum drug family; and NV-128, an investigational cancer compound to promote cancer cell death by targeting the specific protein regulatory pathway in ovarian cancer cells. It is also conducting a Phase II ...
BRIM3: Updated overall survival (OS) results for BRIM3, a Phase III randomized, open-label, multicenter trial comparing BRAF inhibitor vemurafenib (vem) with dacarbazine (DTIC) in previously untreated patients with BRAF V600E mutated melanoma. Abstract #8502.